Moleculin Biotech Inc Stock News

Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion

Research analysts at Maxim Group began coverage on shares of Moleculin Biotech (NASDAQ:MBRX) in a research report issued to clients and investors on Thursday, TipRanks reports. The brokerage set a “

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Moleculin Biotech (MBRX), with a price target of $3.00. The company's

In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Moleculin Biotech (MBRX – Research

Gainers Moleculin Biotech Inc (NASDAQ: MBRX) shares jumped 125.7% to close at $1.27 on Wednesday after it said that independent research found 2-deoxy-D-glucose (2-DG)to reduce...

Toward the end of trading Wednesday, the Dow traded up 2.73% to 23,272.17 while the NASDAQ rose 2.04% to 8,048.18. The S&P also rose, gaining 2.76% to 2,732.88. The U.S. is...

Gainers Moleculin Biotech Inc (NASDAQ: MBRX) shares climbed 174% to $1.54 after it said that independent research found 2-deoxy-D-glucose (2-DG)to reduce replication of...

Midway through trading Wednesday, the Dow traded up 2.49% to 23218.45 while the NASDAQ rose 2.01% to 8045.99. The S&P also rose, gaining 2.32% to 2,721.21. The U.S. is now the...

Following the market opening Wednesday, the Dow traded up 0.56% to 22,780.65 while the NASDAQ rose 0.48% to 7,925.28. The S&P also rose, gaining 0.57% to 2,674.44. The U.S. is...

The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue s

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moleculin Biotech (MBRX

While some firms have been filing for patents to protect their coronavirus treatment innovations, others have faced ultimatums by government to hand over their IP rights during this time of global cri

In addition to causing chaos in markets and economies around the world, the spread of the COVID-19 coronavirus has put the biotechnology and health care industries under the...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ...

Gainers Chanticleer Holdings, Inc. (NASDAQ: BURG) shares rose 117.1% to $1.52 in pre-market trading after gaining around 35% on Wednesday. CorePoint Lodging Inc. (NYSE: CPLG)...